• 1:04

  Matching mechanisms and therapeutics: new avenues to explore

  Ione Woollacott

  Ione Woollacott, MD, MRCP from the Institute of Neurology, University College London, London, UK discusses the work she presented at…
• 1:56

  The role of inflammation in FTD

  Ione Woollacott

  The protein progranulin has been associated with familial frontotemporal dementia (FTD), an inherited form of the disorder. Progranulin has also…
• 1:24

  An introduction to familial frontotemporal dementia

  Ione Woollacott

  Ione Woollacott, MD, MRCP from the Institute of Neurology, University College London, UK discusses the etiology of familial frontotemporal dementia…
• 3:39

  Traumatic brain injuries and the development of dementia

  Daniel Perl

  Traumatic brain injuries (TBI) are common, and have been associated with an increased risk of developing dementia in later life,…
• 3:31

  ALS and frontotemporal dementia: on a continuum or part of a spectrum of disorders?

  Manuela Neumann

  Manuela Neumann, MD from the University Hospital Tuebingen, Tuebingen, Germany discusses the question of whether amyotrophic lateral sclerosis (ALS) and…
• 1:38

  The neuropathology and genetics of ALS and FTD

  Manuela Neumann

  Manuela Neumann, MD from the University Hospital Tuebingen, Tuebingen, Germany provides an overview of the neuropathology and genetics of amyotrophic…
• 1:27

  Genetic counseling for dementia

  Daniela Galimberti

  Daniela Galimberti, PhD from the University of Milan, Milan, Italy discusses genetic counseling in dementia at the 2017 Congress of…
• 2:45

  The clinical role of MRI in dementia

  Steen Hasselbalch

  Steen Hasselbalch, MD, University of Copenhagen, Copenhagen, Denmark, discusses his session that reviews the role of magnetic resonance imaging (MRI)…
• 1:27

  Clinical features of focal dementias

  Stefano Cappa

  Stefano Cappa, MD, from Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy, provides an overview of his workshop, which examines…
• 1:27

  An update on disease-modifying treatments for dementia

  Doug Brown

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Doug Brown,…